Touting CD161 as a Test Case for Single-Cell Tech, Longwood-backed Immunitas Bags $58M for Next-Gen I/O Work August 19, 2021
Clinical Validation of a Targeted Methylation-Based Multi-Cancer Early Detection Test Using an Independent Validation Set June 25, 2021
Grail Launches Long-Awaited Galleri Blood Test, its Groundbreaking Multi-Cancer Screening Diagnostic June 25, 2021
Stephen Elledge’s Harvard lab Again Proves Fruitful with the Launch of High-Throughput Antibody Startup June 23, 2021
